Annual Total Expenses
$22.31 M
+$4.39 M+24.51%
December 31, 2023
Summary
- As of February 23, 2025, GANX annual total expenses is $22.31 million, with the most recent change of +$4.39 million (+24.51%) on December 31, 2023.
- During the last 3 years, GANX annual total expenses has risen by +$18.80 million (+535.87%).
- GANX annual total expenses is now at all-time high.
Performance
GANX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$4.46 M
-$3.72 M-45.51%
September 30, 2024
Summary
- As of February 23, 2025, GANX quarterly total expenses is $4.46 million, with the most recent change of -$3.72 million (-45.51%) on September 30, 2024.
- Over the past year, GANX quarterly total expenses has stayed the same.
- GANX quarterly total expenses is now -45.51% below its all-time high of $8.18 million, reached on June 30, 2024.
Performance
GANX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
GANX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.5% | 0.0% |
| 3 y3 years | +535.9% | 0.0% |
| 5 y5 years | +2026.8% | 0.0% |
GANX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.5% | -45.5% | +37.1% |
| 5 y | 5-year | at high | +941.8% | -45.5% | +759.3% |
| alltime | all time | at high | +2026.8% | -45.5% | +759.3% |
Gain Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.46 M(-45.5%) |
| Jun 2024 | - | $8.18 M(+86.9%) |
| Mar 2024 | - | $4.38 M(-0.7%) |
| Dec 2023 | $22.31 M(+24.5%) | $4.41 M(-9.8%) |
| Sep 2023 | - | $4.88 M(-36.8%) |
| Jun 2023 | - | $7.73 M(+46.3%) |
| Mar 2023 | - | $5.29 M(+15.9%) |
| Dec 2022 | $17.92 M(+28.1%) | $4.56 M(-4.0%) |
| Sep 2022 | - | $4.75 M(-9.9%) |
| Jun 2022 | - | $5.27 M(+58.1%) |
| Mar 2022 | - | $3.33 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $13.99 M(+298.8%) | - |
| Dec 2021 | - | $3.25 M(-30.3%) |
| Sep 2021 | - | $4.66 M(+29.4%) |
| Jun 2021 | - | $3.60 M(+45.8%) |
| Mar 2021 | - | $2.47 M(+52.2%) |
| Dec 2020 | $3.51 M(+63.8%) | - |
| Dec 2020 | - | $1.62 M(+96.8%) |
| Sep 2020 | - | $825.80 K(+53.3%) |
| Jun 2020 | - | $538.80 K(+3.8%) |
| Mar 2020 | - | $518.90 K |
| Dec 2019 | $2.14 M(+104.2%) | - |
| Dec 2018 | $1.05 M | - |
FAQ
- What is Gain Therapeutics annual total expenses?
- What is the all time high annual total expenses for Gain Therapeutics?
- What is Gain Therapeutics annual total expenses year-on-year change?
- What is Gain Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Gain Therapeutics?
- What is Gain Therapeutics quarterly total expenses year-on-year change?
What is Gain Therapeutics annual total expenses?
The current annual total expenses of GANX is $22.31 M
What is the all time high annual total expenses for Gain Therapeutics?
Gain Therapeutics all-time high annual total expenses is $22.31 M
What is Gain Therapeutics annual total expenses year-on-year change?
Over the past year, GANX annual total expenses has changed by +$4.39 M (+24.51%)
What is Gain Therapeutics quarterly total expenses?
The current quarterly total expenses of GANX is $4.46 M
What is the all time high quarterly total expenses for Gain Therapeutics?
Gain Therapeutics all-time high quarterly total expenses is $8.18 M
What is Gain Therapeutics quarterly total expenses year-on-year change?
Over the past year, GANX quarterly total expenses has changed by $0.00 (0.00%)